Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Language Dysfunction in Benign Rolandic Epilepsy
NCT00181116Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levetiracetam in Benign Rolandic Epilepsy (BECTS), sponsored by Johns Hopkins University. Primary endpoint: Language improvement at 6 months. Started Mar 2005; status: completed.
02
Drugs
levetiracetam
03
Conditions
Benign Rolandic Epilepsy (BECTS)
Beyond the preview
Go deeper on NCT00181116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181116.